SCHEMBL124133

SCHEMBL124133

O=S(=O)(O)c1cc(S(=O)(=O)O)cc(S(=O)(=O)O)c1.[NaH].[NaH].[NaH]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.55
FYN P06241 1/20 0.55
ING2 Q9H160 1/20 0.52
TSHR P16473 3/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
LMNA P02545 1/20 0.48
ALDH1A1 P00352 5/20 0.46
NT5E P21589 3/20 0.46
HSD17B10 Q99714 4/20 0.44
TDP1 Q9NUW8 2/20 0.44
CASP6 P55212 3/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NSD2 O96028 3/20 0.40
GAA P10253 1/20 0.40
PLCG1 P19174 1/20 0.40
DNMT1 P26358 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
DUSP3 P51452 1/20 0.39
PTPN5 P54829 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5013229 1.00 LCK (0.55) LCKFYNING2TSHRSMN1; SMN2
SCHEMBL219222 0.96 LCK (0.57) LCKFYNING2TSHRSMN1; SMN2
SCHEMBL216136 0.93 LCK (0.55) LCKFYNING2TSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL9775388 0.93 LCK (0.55) LCKFYNING2TSHRSMN1; SMN2
SCHEMBL9220939 0.93 LCK (0.55) LCKFYNING2TSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL23302213 0.93 LCK (0.55) LCKFYNING2TSHRSMN1; SMN2
SCHEMBL26691692 0.88 LMNA (0.52) LCKFYNING2TSHRSMN1; SMN2
SCHEMBL27752734 0.88 LMNA (0.52) LCKFYNING2TSHRSMN1; SMN2
SCHEMBL10893545 0.86 ALDH1A1 (0.58) LCKFYNING2TSHRSMN1; SMN2
SCHEMBL7803304 0.84 LCK (0.48) LCKFYNING2TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111788472-B Method, reagent and chip for determining concentration of analyte in biological sample 泰尔茂株式会社 2023-12-15 CN disclosed
US-11815448-B2 Method, reagent, and chip for measuring analyte concentration in specimen TERUMO KABUSHIKI KAISHA (JP) 2023-11-14 US disclosed
CN-110291185-B Blood sugar level measurement chip and blood sugar level measurement device set 泰尔茂株式会社 2022-08-09 CN disclosed
CN-108368472-B Blood sugar level measuring reagent, blood sugar level measuring chip, and blood sugar level measuring apparatus set 泰尔茂株式会社 2021-09-21 CN disclosed
US-20200371020-A1 METHOD, REAGENT, AND CHIP FOR MEASURING ANALYTE CONCENTRATION IN SPECIMEN TERUMO KABUSHIKI KAISHA (JP) 2020-11-26 US disclosed
EP-3736571-A1 METHOD, REAGENT, AND CHIP, FOR MEASURING ANALYTE CONCENTRATION IN BIOLOGICAL SAMPLE TERUMO KABUSHIKI KAISHA (JP) 2020-11-11 EP disclosed
CN-111788472-A Method, reagent and chip for determining concentration of analyte in biological sample 泰尔茂株式会社 2020-10-16 CN disclosed
WO-2019171731-A1 METHOD, REAGENT, AND CHIP, FOR MEASURING ANALYTE CONCENTRATION IN BIOLOGICAL SAMPLE テルモ株式会社 2019-09-12 WO disclosed
EP-2006738-B1 Lithographic printing plate precursor FUJIFILM CORP (JP) 2017-09-06 EP disclosed
US-9032876-B2 Lithographic printing plate precursor, lithographic printing plate platemaking method, and polymerizable monomer FUJIFILM CORPORATION (JP) 2015-05-19 US disclosed
EP-2048000-A2 Plate making method of lithographic printing plate precursor FUJIFILM Corporation (JP) 2009-04-15 EP disclosed
US-20090075208-A1 PLATE MAKING METHOD OF LITHOGRAPHIC PRINTING PLATE PRECURSOR FUJIFILM CORPORATION (JP) 2009-03-19 US disclosed
US-20090047601-A1 PLANOGRAPHIC PRINTING PLATE PRECURSOR AND PRINTING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2009-02-19 US disclosed
US-20080318155-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PLATE MAKING METHOD FUJIFILM CORPORATION (JP) 2008-12-25 US disclosed
EP-2006738-A2 Lithographic printing plate precursor and lithographic printing method Fujifilm Corporation (JP) 2008-12-24 EP disclosed
US-20080286685-A1 PLANOGRAPHIC PRINTING PLATE PRECURSOR AND PRINTING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2008-11-20 US disclosed
EP-1992482-A2 Planographic printing plate precursor and printing method using the same FUJIFILM Corporation (JP) 2008-11-19 EP disclosed
US-20070214987-A1 Lithographic printing plate precursor FUJIFILM CORPORATION 2007-09-20 US disclosed
EP-1834766-A2 Lithographic printing plate precursor FUJIFILM Corporation (JP) 2007-09-19 EP disclosed
EP-0421660-A2 Improvements to electrical cells Ever Ready Limited (GB) 1991-04-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200371020-A1 METHOD, REAGENT, AND CHIP FOR MEASURING ANALYTE CONCENTRATION IN SPECIMEN STUB1, MPO, ALDH1A2 LCK 3347/4885FYN 2863/4885ING2 3918/4885
US-11815448-B2 Method, reagent, and chip for measuring analyte concentration in specimen STUB1, MPO, ALDH1A2 LCK 3347/4885FYN 2863/4885ING2 3918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.